Loading…
Loading…
DaVita Inc
NYSE · Stock Profile · Market Cap $10.42B
Current Price
$148.83
-0.77%GoodMoat Value
$383.73
157.8% undervaluedA large-cap company with a $10.4B market cap.
Forward estimates use 11.7% FCF growth (CAGR)
Net Debt: 12.1B
3.2B
FY24
3.3B
FY24
12.8B
FY24
3.2B
FY25
3.4B
FY25
3.4B
FY25
13.6B
FY25
223M
FY24
215M
FY24
936M
FY24
163M
FY25
199M
FY25
150M
FY25
747M
FY25
DaVita is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey— from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of December 31, 2025, DaVita served approximately 295,000 patients at 3,242 outpatient dialysis centers, of which 2,657 centers were located in the United States and 585 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere.
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYSE
Country
Colorado, USA
Price sits at 86% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
DaVita is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey— from slowing the progression of kidney disease to helping support transplantation. This includes ensuring they are supported at home, in dialysis centers, in the hospital and in skilled nursing facilities. As of December 31, 2025, DaVita served approximately 295,000 patients at 3,242 outpatient dialysis centers, of which 2,657 centers were located in the United States and 585 centers were located in 14 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere.
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYSE
Country
Colorado, USA